ABCB1 and neoplasm: Our results support the observation of Duensing et al.[36] of a longer progression-free survival in patients with no or very few MDR-1 positive tumour cells compared to the group of patients with several positive tumour cells, but are in disagreement with the report of Oudard et al.[37].